Cargando…

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?

The use of granulocyte colony-stimulating factor (G-CSF) in patients with haematological malignancies is associated with less febrile neutropenia episodes. But in the presence of COVID-19 infection, the administration of G-CSF is challenging as it may trigger a robust inflammatory reaction resulting...

Descripción completa

Detalles Bibliográficos
Autor principal: Malek, Alexandre E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781165/
https://www.ncbi.nlm.nih.gov/pubmed/33398065
http://dx.doi.org/10.1038/s41416-020-01195-8